share_log

Assessing Hims & Hers Health: Insights From 7 Financial Analysts

Assessing Hims & Hers Health: Insights From 7 Financial Analysts

評估Hims & Hers健康:來自7位財務分析師的見解
Benzinga ·  02:00
Hims & Hers Health (NYSE:HIMS) underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Hims & Hers Health(紐交所:HIMS)在上個季度接受了7位分析師的分析,顯示出從看好到看淡的各種觀點。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級,展示了過去30天內不斷變化的情緒,並將其與前幾個月進行了比較。
In the assessment of 12-month price targets, analysts unveil insights for Hims & Hers Health, presenting an average target of $24.0, a high estimate of $28.00, and a low estimate of $20.00. This current average has increased by 9.09% from the previous average price target of $22.00.
在對12個月的價格目標進行評估時,分析師爲Hims & Hers Health揭示了見解,提出了平均目標價24.0美元,最高估價爲28.00美元,最低估價爲20.00美元。當前這一平均值比之前的22.00美元的平均目標價格上漲了9.09%。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級:詳細剖析
The perception of Hims & Hers Health...
通過最近的分析...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論